- Home
- SNYR vs COCP Comparison
SNYR vs COCP Comparison
Compare SNYR & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNYR
- COCP
- Stock Information
- Founded
- SNYR 2010
- COCP 2006
- Country
- SNYR United States
- COCP United States
- Employees
- SNYR N/A
- COCP N/A
- Industry
- SNYR
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- SNYR
- COCP Health Care
- Exchange
- SNYR NYSE
- COCP Nasdaq
- Market Cap
- SNYR 16.6M
- COCP 15.4M
- IPO Year
- SNYR N/A
- COCP N/A
- Fundamental
- Price
- SNYR $3.16
- COCP $1.80
- Analyst Decision
- SNYR Strong Buy
- COCP Strong Buy
- Analyst Count
- SNYR 1
- COCP 1
- Target Price
- SNYR $10.00
- COCP $6.00
- AVG Volume (30 Days)
- SNYR 107.9K
- COCP 22.5K
- Earning Date
- SNYR 08-24-2025
- COCP 08-13-2025
- Dividend Yield
- SNYR N/A
- COCP N/A
- EPS Growth
- SNYR N/A
- COCP N/A
- EPS
- SNYR 0.30
- COCP N/A
- Revenue
- SNYR $33,592,914.00
- COCP N/A
- Revenue This Year
- SNYR $37.83
- COCP N/A
- Revenue Next Year
- SNYR $18.39
- COCP N/A
- P/E Ratio
- SNYR $10.26
- COCP N/A
- Revenue Growth
- SNYR N/A
- COCP N/A
- 52 Week Low
- SNYR $0.36
- COCP $1.12
- 52 Week High
- SNYR $10.00
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- SNYR N/A
- COCP 69.71
- Support Level
- SNYR N/A
- COCP $1.46
- Resistance Level
- SNYR N/A
- COCP $1.60
- Average True Range (ATR)
- SNYR 0.00
- COCP 0.08
- MACD
- SNYR 0.00
- COCP 0.02
- Stochastic Oscillator
- SNYR 0.00
- COCP 92.31
About SNYR SYNERGY CHC CORP
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).